On 2025-05-08, Trevi Therapeutics, Inc. (TRVI) announced earnings per share of $-0.09 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.13.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-0.11 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $-0.13 | $-0.09 |
| 2025-03-18 | 2024-12-31 | $-0.12 | $-0.11 |
| 2024-11-06 | 2024-09-30 | $-0.12 | $-0.13 |
| 2024-08-08 | 2024-06-30 | $-0.11 | $-0.12 |
| 2024-05-07 | 2024-03-31 | $-0.09 | $-0.11 |
| 2024-03-20 | 2023-12-31 | $-0.10 | $-0.08 |
| 2023-11-09 | 2023-09-30 | $-0.09 | $-0.08 |
| 2023-08-10 | 2023-06-30 | $-0.09 | $-0.07 |
| 2023-05-11 | 2023-03-31 | $-0.08 | $-0.06 |
| 2023-03-16 | 2022-12-31 | $-0.11 | $-0.06 |
| 2022-11-10 | 2022-09-30 | $-0.15 | $-0.12 |
| 2022-08-11 | 2022-06-30 | $-0.21 | $-0.14 |
| 2022-05-12 | 2022-03-31 | $-0.31 | $-0.24 |
| 2022-03-17 | 2021-12-31 | $-0.34 | $-0.28 |
| 2021-11-10 | 2021-09-30 | $-0.33 | $-0.34 |
| 2021-08-12 | 2021-06-30 | $-0.46 | $-0.49 |
| 2021-05-13 | 2021-03-31 | $-0.49 | $-0.43 |
| 2021-03-25 | 2020-12-31 | $-0.45 | $-0.52 |
| 2020-11-12 | 2020-09-30 | $-0.59 | $-0.41 |
| 2020-08-13 | 2020-06-30 | $-0.52 | $-0.41 |
| 2020-05-07 | 2020-03-31 | $-0.44 | $-0.48 |
| 2020-03-16 | 2019-12-31 | $-0.52 | $-0.19 |
| 2019-11-14 | 2019-09-30 | $-0.48 | $-0.41 |
| 2019-08-12 | 2019-06-30 | $-0.41 | $-0.63 |